No.
|
Examinationa
|
Locationb
|
Diagnosisc
|
Histologyd
|
Stage
|
Survivale
|
---|
1
|
b
|
per
|
CT + spu
|
SQC
|
IIIa
| |
2
|
r
|
per
|
CT + spu
|
SQC
|
Ia
|
29
|
3
|
b
|
per
|
CT
|
ADO
|
Ia
| |
4g
|
b
|
per
|
CT
| | |
7
|
5
|
r
|
per
|
CT
|
LAC
|
IIIb
|
23
|
6
|
b
|
per
|
CT
|
ADO
|
Ia
|
64
|
7
|
b
|
cen
|
CT + spu
|
SQC
|
IV
|
21
|
8
|
b
|
cen
|
CT + spu
|
SQC
|
Ia
| |
9
|
r
|
cen
|
CT + spu
|
SQC
|
IIb
|
33
|
10
|
b
|
cen
|
CT + spu
|
SQC
|
Ib
|
18
|
11
|
b
|
cen
|
CT
|
SMC
|
Ia
|
28
|
12
|
r
|
cen
|
spu
|
SQC
|
IIIb
|
72
|
13
|
i
|
cen
| |
SMC
|
IIb
|
14
|
14
|
i
| | | | |
35
|
15h
|
f
| | | | | |
16
|
f
| | |
SMC
|
IIIb
|
k
|
17
|
f
| | |
SMC
|
IIb
|
k
|
18
|
f
| | | |
IIIb
|
k
|
- aExamination with significant result: b = baseline, r = re-examination, i = interval, f = follow-up.
- bLocation of tumour: per = peripheral, cen = central.
- cResult indicating diagnosis: CT = low-dose spiral computed tomography, spu = sputum cytology.
- dHistology of lung carcinoma: SQC = squamous cell, ADO = adeno, LAC = large cell, SMC = small cell.
- eSurvival time after beginning of initial clinical symptoms indicating the disease (months).
- gDied suddenly 2004 before biopsy could be taken, diagnosis unequivocal clinically and on CT.
- hDied 2008 with lung cancer after refusing further examinations.
- kAlive by the end of follow-up.
- In patients with missing data the documented histories were incomplete or could not be retrieved in time.